|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Service | |||||
| Product Sales | |||||
| Total revenue | |||||
| Cost of sales, excluding depreciation and amortization: | |||||
| Cost of sales | |||||
| Service | |||||
| Product Sales | |||||
| Total cost of sales | |||||
| Cost of product sales | |||||
| Selling, general and administrative expenses | |||||
| Depreciation and amortization | |||||
| Loss on sale of business | |||||
| Net operating income | |||||
| Other expense | |||||
| Interest expense, net | |||||
| Other finance income | |||||
| Total other expense, net | |||||
| Net (loss) income before income taxes | |||||
| Income tax (expense) benefit | |||||
| Net (loss) income | |||||
| Other comprehensive (loss) income: | |||||
| Foreign currency translation (loss) gain | |||||
| Deferred tax on foreign currency translation (loss) gain | |||||
| Change in fair value of hedging instrument | |||||
| Reclassification of gain on hedging instrument to comprehensive income | |||||
| Deferred tax on movement in hedging instrument | |||||
| Actuarial gains on pension plan | |||||
| Deferred tax on actuarial gains on pension plan | |||||
| Other comprehensive (loss) income | |||||
| Comprehensive (loss) income | |||||
| Net (loss) income per common share – basic | |||||
| Net (loss) income per common share - diluted | |||||
| Weighted average number of shares outstanding during the year – basic | |||||
| Weighted average number of shares outstanding during the year - diluted | |||||
| Supplemental disclosure of stock-based compensation expense | |||||
| Selling, general and administrative expenses | |||||
Loading...